Ultima HCG 10000IU US

Human Chorionic Gonadotropin is a potent polypeptide hormone present in the bodies of pregnant women. It is primarily utilized in medical treatments for conditions like cryptorchidism, female infertility, hypogonadism (low testosterone), and weight loss.

HCG is also frequently employed by anabolic steroid users as an adjunct or post-use treatment. During steroid use, it helps counteract hormonal suppression caused by steroids. After finishing steroid use, it aids in a more effective recovery process.

One of the main uses of HCG today is as a weight loss aid. The HCG diet has gained considerable traction in Western medicine, though its overall effectiveness is a highly disputed issue. Both the American Medical Association and the American Society of Bariatric Physicians have criticized the HCG diet, asserting that weight loss is primarily the result of the severe caloric restriction that often accompanies such a regimen. HCG diets generally consist of a mere 500 calories per day. Upon examining HCG's metabolic effects, we discover it lacks thyroid-stimulating capabilities, is not a beta-2 agonist, does not curb appetite, and possesses no thermogenic or fat-burning properties. Despite the criticisms, numerous doctors report success with the HCG diet, but its association with starvation raises significant health concerns for long-term adherence. Currently, there is no conclusive evidence that the HCG diet alone results in weight loss distinct from the effects of caloric restriction. The debate surrounding this diet is likely to persist for many years.

The impact of HCG on anabolic steroid users can be categorized into two areas: post-cycle therapy (PCT) and use during a cycle. Anabolic steroids suppress natural testosterone production, with the extent of suppression varying based on the specific steroids and dosages used. Once all anabolic steroid use ceases, testosterone production will gradually resume, provided there was no existing low testosterone condition or significant disruption to the HPTA from improper steroid practices. However, this recovery is slow, leading to low testosterone levels and associated symptoms, which can be frustrating and result in muscle loss due to increased cortisol levels. Therefore, many steroid users implement a PCT plan to facilitate recovery. While PCT speeds up recovery, it doesn't automatically restore normal testosterone levels but ensures sufficient testosterone for essential bodily functions during the recovery phase.

Various PCT protocols exist, often involving SERMs such as Nolvadex (Tamoxifen Citrate) and/or Clomid (Clomiphene Citrate). Many find that initiating a PCT plan with HCG before starting SERM treatment enhances overall recovery, as HCG acts like LH and prepares the body for upcoming SERM therapy, resulting in a more efficient recovery process.

The second advantageous use of HCG for anabolic steroid users is during a steroid cycle. Steroid use can lead to testicular atrophy due to suppressed natural testosterone levels. Supplementing with HCG during this period helps maintain testicular size. While this is primarily a cosmetic effect without strategic benefits, it may facilitate easier recovery after discontinuation of steroids. Nonetheless, there is a significant risk: the body can easily become dependent on HCG for its LH needs. Although low testosterone patients using HCG face no issues with dependency, non-low testosterone users must use HCG cautiously and monitor their dosage to avoid dependency. Overuse of HCG can lead to more harm than many anabolic steroids among steroid users. While using HCG during a cycle can aid in an efficient recovery, it must be approached responsibly. Regardless of use—whether during a cycle or as a precursor to PCT—HCG must be managed carefully.

For anabolic steroid users taking HCG during their cycle, a typical dose would be 250 iu every 4-5 days, providing sufficient HCG to achieve desired effects without exceeding limits to protect future natural testosterone production.

Finally, there are two appropriate protocols for HCG dosing during PCT. The first involves administering 1,500-4,000 iu every 3-4 days for 2-3 weeks, after which SERM therapy resumes. A second, potentially more effective method is to give HCG daily at 500-1,000 iu for 10 consecutive days, followed by SERM therapy afterward.

Timing of HCG is critical if used during PCT. If your steroid cycle ended with large ester steroids, HCG therapy should start 10 days after the last injection, followed by SERM therapy upon the conclusion of HCG use. Conversely, if the cycle concluded with small ester steroids, HCG therapy should commence 3 days post-injection, followed by SERM therapy after completing the HCG regimen.